Background
Epilepsy caused by a
KCNQ2
gene mutation usually manifests as neonatal seizures during the first week of life. The genotypes and phenotypes of
KCNQ2
mutations are noteworthy.
Methods
The
KCNQ2
sequencings done were selected from 131 nonconsanguineous pediatric epileptic patients (age range: 2 days to 18 years) with nonlesional epilepsy.
Results
Seven (5%) index patients had verified
KCNQ2
mutations: c.387+1 G>T (splicing), c.1741 C>T (p.Arg581*), c.740 C>T p.(Ser247Leu), c.853 C>A p.(Pro285Thr), c.860 C>T p.(Thr287Ile), c.1294 C>T p.(Arg432Cys), and c.1627 G>A p.(Val543Met). We found, after their paternity had been confirmed, that three patients had de novo p.(Ser247Leu), p.(Pro285Thr), and p.(Thr287Ile) mutations and neonatal‐onset epileptic encephalopathy; however, their frequent seizures remitted after they turned 6 months old. Those with the c.387+1G>T (splicing), (p.Arg581*), and p.(Val543Met) mutations presented with benign familial neonatal convulsions. In addition to their relatives, 14 patients had documented
KCNQ2
mutations, and 12 (86%) had neonatal seizures. The seizures of all five patients treated with oxcarbazepine remitted.
Conclusion
KCNQ2‐
related epilepsy led to varied outcomes (from benign to severe) in our patients.
KCNQ2
mutations accounted for 13% of patients with seizure onset before 2 months old in our study.
KCNQ2
mutations can cause different phenotypes in children. p.(Pro 285Thr) is a novel mutation, and the p.(Pro 285Thr), p.(Ser247Leu), and p.(Thr287Ile) variants can cause neonatal‐onset epileptic encephalopathy.